Select Page
Responsive Centered YouTube Video
Critical insights on COVID-19 waves and concerns shared by conference speakers.
  • History lesson on 1918 flu pandemic waves and political challenges. 0:55

  • Prediction of a potential third wave of COVID-19 based on scientific analysis. 1:49

  • Speaker Charles Rickson’s focus on scientific censorship and gain of function research. 2:17

  • Terrain Health Center’s commitment to treating long-haul COVID patients and vaccine injuries. 3:14

Insights on Omicron variant entry mechanism and concerns regarding TMPRSS protein.
  • Omicron variant uses a slower endosomal entry mechanism compared to earlier variants. 5:25

  • Transition to endosomal entry is more efficient for Omicron in infecting cells. 6:32

  • Concerns arise due to efficient virus entry mechanism of Omicron and TMPRSS protein distribution. 7:27

  • TMPRSS protein plays a crucial role in virus entry and is located in upper airways and lungs. 7:27

Insightful discussion on potential threats posed by a new variant combining characteristics of Delta and Omicron.
  • Comparison of Deltavirus and Omicron in terms of lung impact. 7:37

  • Concern about a potential blend of speed and efficiency in a new variant. 8:02

  • Prediction of increased severe lung disease due to inflammation. 8:29

  • Encouragement to attend upcoming conference for more information. 9:55

  • Importance of staying informed and prepared for evolving pandemic dynamics. 9:55

  • Speakers’ backgrounds and areas of expertise highlighted. 10:39

  • Focus on understanding toxic responses to virus and vaccines. 11:10

Insights from diverse medical professionals on COVID-19 research and treatment strategies.
  • Thymus gland’s role in virus disruption and aging acceleration discussed. 11:33

  • Supporting oral, nasal, and gut microbiomes to reduce Spike replication presented. 12:08

  • Research on secondary substances and herbal medicine development highlighted. 12:44

  • Investigations into SARS origins, bioWarfare overlap, and amyloidosis impact discussed. 13:48

  • Blood aphoresis systems and anti-clotting treatments proposed for COVID-19 patients. 14:35

  • Association between Long COVID and Muscle Activation Syndrome emphasized. 15:47

  • Research on Long COVID, vaccine injuries, and treatment strategies shared. 16:12

Insights on research advancements in immunodeficiency, cardiovascular disease, and RNA technology.
  • Discussion on persistent Spike’s impact on disease expressions 16:32

  • Presentation on lipid nanoparticle and RNA technology in medical research 17:00

  • Exploration of contamination concerns with plasmids and their effects on the human body 17:46

  • Analysis of Spike’s role in microplasts causation 18:55

  • Encouragement for active participation in upcoming conference 19:32